Column Group IV GP, LP, 10% Owner at Eikon Therapeutics, Inc. (EIKN), bought 89,200 shares at $11.56 ($1.0M) on 2026-09-03, disclosed to the SEC on 2026-09-08.
Open-market purchase of $1.0M EIKN by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| Filing → |
| NGM | BUY | 2022-05-31 | $572K | — | Filing → |